Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study

Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients

(2021) Janine M. Simons et al.   ANNALS OF SURGICAL ONCOLOGY

False Negativity of Targeted Axillary Dissection in Breast Cancer

(2021) George Kirkilesis et al.   Breast Care

Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature

(2020) Malgorzata Banys-Paluchowski et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Targeted axillary dissection of carbon‐tattooed metastatic lymph nodes in combination with post–neo‐adjuvant sentinel lymph node biopsy using 1% methylene blue in breast cancer patients

(2020) Emad Khallaf et al.   Breast Journal

Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial)

(2020) Geok Hoon Lim et al.   Cancer Medicine

Evolving Role of Magseed in Wireless Localization of Breast Lesions: Systematic Review and Pooled Analysis of 1,559 Procedures

(2020) RITIKA GERA et al.   ANTICANCER RESEARCH

Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers

(2020) Alison Laws et al.   ANNALS OF SURGICAL ONCOLOGY

Savi Scout® Radar Localisation of Non-palpable Breast Lesions: Systematic Review and Pooled Analysis of 842 Cases

(2020) IHAM KASEM et al.   ANTICANCER RESEARCH

Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization

(2020) James Sun et al.   Clinical Breast Cancer

Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?

(2020) Geok Hoon Lim et al.   ONCOLOGIST

Use of Hologic LOCalizer radiofrequency identification (RFID) tags to localise impalpable breast lesions and axillary nodes: experience of the first 150 cases in a UK breast unit

(2020) S. Lowes et al.   CLINICAL RADIOLOGY

Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up

(2020) Sabrina Kahler-Ribeiro-Fontana et al.   EJSO

Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de‐escalate surgical treatments

(2020) Antonio Esgueva et al.   JOURNAL OF SURGICAL ONCOLOGY

Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer

(2020) Antonio Mariscal Martínez et al.   SURGICAL ONCOLOGY-OXFORD

Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment

(2019) Ioannis Natsiopoulos et al.   Clinical Breast Cancer

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2019) F Cardoso et al.   ANNALS OF ONCOLOGY

Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions

(2019) Caroline McGugin et al.   BREAST CANCER RESEARCH AND TREATMENT

Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: a feasibility study

(2019) Won Hwa Kim et al.   BMC CANCER

177PDProspective, multicenter registry trial to evaluate the clinical feasibility of targeted axillary dissection (TAD) in patients (pts) with breast cancer (BC) and core biopsy proven axillary involvement (cN+)

(2019) M Reinisch et al.   ANNALS OF ONCOLOGY

Heterogeneous Responses of Axillary Lymph Node Metastases to Neoadjuvant Chemotherapy are Common and Depend on Breast Cancer Subtype

(2019) Antonia Glaeser et al.   ANNALS OF SURGICAL ONCOLOGY

Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery

(2019) Tanir M. Allweis et al.   EJSO

Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy

(2019) Rajesh Balasubramanian et al.   EJSO

A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer

(2018) Olga Kantor et al.   ANNALS OF SURGICAL ONCOLOGY

Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy

(2018) Steffi Hartmann et al.   EJSO

Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy

(2018) Alison U. Barron et al.   JAMA Surgery

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

(2018) Jean-Marc Classe et al.   BREAST CANCER RESEARCH AND TREATMENT

SEOM clinical guidelines in early stage breast cancer (2018)

(2018) F. Ayala de la Peña et al.   Clinical & Translational Oncology

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial

(2018) Guido Henke et al.   Trials

Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery

(2017) Audree B. Tadros et al.   JAMA Surgery

Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients

(2016) Hiba El Hage Chehade et al.   AMERICAN JOURNAL OF SURGERY

Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy

(2016) Judy C. Boughey et al.   ANNALS OF SURGERY

Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes

(2016) Emilia J. Diego et al.   ANNALS OF SURGICAL ONCOLOGY

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

(2016) Abigail S. Caudle et al.   JOURNAL OF CLINICAL ONCOLOGY

Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients

(2015) Mila Donker et al.   ANNALS OF SURGERY

Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes

(2015) Donna Plecha et al.   ANNALS OF SURGICAL ONCOLOGY

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

(2015) Jean-Francois Boileau et al.   JOURNAL OF CLINICAL ONCOLOGY

Initial Results with Preoperative Tattooing of Biopsied Axillary Lymph Nodes and Correlation to Sentinel Lymph Nodes in Breast Cancer Patients

(2014) Nicole Choy et al.   ANNALS OF SURGICAL ONCOLOGY

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer

(2013) Judy C. Boughey   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

(2013) Thorsten Kuehn et al.   LANCET ONCOLOGY